SUMMARY Fifty one patients with ankylosing spondylitis (AS) were typed for HLA-A, B, C, DR, and DO antigens. The antigen frequencies were compared with those of a normal population and with a B27 positive control group. All but one of the patients with AS were HLA-B27 positive. A positive linkage disequilibrium between Cwl, Cw2, DR1, and the B27 antigen was observed. Patients with AS showed a significant increase in DQw2 antigen compared with the B27 positive control group. No differences in antigenic frequencies were observed in patients having peripheral arthritis and patients with only axial involvement. Seven out of nine patients (78%) with an erosive peripheral arthritis were DR7 positive, suggesting that DR7 or genes closely linked could be related with a more aggressive peripheral joint involvement in patients with AS.
Since 1973 ankylosing sponclylitis (AS) has been known to be very strongly associated with the HLA-B27 antigen,1 2 but no convincing relationships between this disease and other HLA class I or class II antigens have been demonstrated.3 4 Although axial arthritis with invariable sacroiliac involvement characterises the disease, many patients have involvement of the peripheral joints at some time during the course of their disease.5 6 The occurrence of peripheral arthritis in patients with AS could be related to environmental factors, absent in patients with only axial involvement, or may reflect differences in additional genetic determinants which may or may not be linked to the B27 antigen.7 To analyse the genetic susceptibility to developing peripheral arthritis in AS a few studies were carried out,4 8 When we compared the antigen frequencies of patients with AS (all but one carrying the B27 antigen) with those of a B27 positive control population a positive linkage disequilibrium between DR1 and B27 positive antigens was observed, which would explain the increase in DR1 in AS observed by other groups,4 14 and suggests that this antigen does not have any role in the disease susceptibility. We also observed a negative linkage disequilibrium between DR7 and B27, which has already been reported.8 12 In contrast, the frequency of DR7 in our patients is similar to that of the general population but markedly greater than that of the B27 positive control group.
In our study DQw2 was increased in patients with AS compared with the B27 positive control group (47% v 16%). We are not aware of any previous analysis of the DQ locus in AS. The existence of a strong negative linkage disequilibrium between B27 and DQw2 was reported during the 9th Histocompatibility Workshop. 12 This unexpected increase of DQw2 (which can be due only in part to the greater frequency of DR7 in our patients, an antigen linked to DQw2) could point to the existence of other genetic markers or the presence of different haplotypes in spondylitic patients and healthy people having the B27 antigen. This latter hypothesis could not be confirmed by Lochead et al,'8 but class II antigens were not studied in their report.
M0ller et al are of the opinion that AS is a multigenic syndrome in which the B27 antigen is not the only genetic factor involved, even though it is the main one.7 19 The expression of these genes in addition to B27 could cause modifications of the clinical course of the disease. Following on from this theory the possibility that patients with AS having peripheral joint involvement would be genetically different from those having only axial involvement has recently been suggested, though results have shown discrepancies.4 8 9 To test whether a genetic susceptibility to develop peripheral arthritis in the course of AS is HLA related we selected patients with peripheral arthritis, most of whom were severely affected. The group with axial involvement only had been followed up for more than 10 years to make sure that they were not prone to develop peripheral arthritis, as peripheral involvement occurs frequently in the first 10 years of the disease.20
We have not found differences in HLA antigenic frequencies between the groups of patients with or without peripheral arthritis. The antigens Cwl, Cw2, and DR1 were increased in both groups because of the linkage disequilibrium with HLA-B27.
An increased frequency of DR4 antigen was found by Miehle et al in AS patients with 'pure peripheral arthritis' involving only wrist, ankle, toe, and finger joints.9 Three patients included in our study had this pattern of joint involvement and none of them carried the DR4 antigen.
A similar DR7 antigen frequency was found in patients with peripheral arthropathy and those having only axial disease. In the group with peripheral involvement there was a relation between the severity of the peripheral arthritis and the DR7 antigen: seven out of the nine patients with an erosive peripheral arthritis were DR7 positive (77-7%). Aaron et al found an increase in the DR7 antigen in AS patients with peripheral arthritis, though the features of arthritis were not reported.8 On the other hand, an increase of DR7 in psoriatic arthritis is well recorded,3 4 21 but none of our patients had psoriasis. Thus the DR7 antigen, or genes closely linked, could be related to the development of a more aggressive peripheral arthritis in AS. Further studies are necessary to confirm this.
The HLA-B27 antigen is the most important marker of AS. In view of our results we cannot exclude the possibility that other genes in the major histocompatibility complex may contribute to the susceptibility and clinical heterogeneity of the disease.
